Skip to content

Haemonetics HAE Ratios & Valuation

Q4 '26Q3 '26Q2 '26Q1 '26Q4 '25
Profitability
Gross margin59%+4.0pp59.4%+6.1pp58.3%+5.6pp56.9%+4.5pp55%+2.2pp
Efficiency
Asset turnover0.6×0.0×0.5×-0.1×0.5×-0.1×0.5×-0.1×0.6×0.0×
Liquidity
Current ratio+1.3×1.7×-2.2×1.6×-1.8×1.7×-2.0×1.6×-0.9×
Leverage
Debt-to-equity1.6×0.0×1.3×0.0×1.4×0.0×1.4×0.0×1.6×+0.7×
Per Share
Book value per share$16.82+3.9%$19.40+8.3%$17.82+3.9%$18.25+3.9%$16.18-13.4%
Valuation
Market capitalization$2.62B-18.0%$3.75B-4.3%$2.35B-42.9%$3.51B-16.7%$3.19B-26.3%
Price / sales-0.4×2.8×0.0×1.8×-1.3×2.6×-0.6×2.3×-1.0×
Price / book3.3×-0.6×4.1×-0.2×2.8×-1.9×-0.7×3.9×-0.6×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are Haemonetics's profit margins?
Haemonetics (HAE) runs a 59.0% gross margin and a 19.0% operating margin, with a 13.3% net margin.
Where do Haemonetics's ratios come from?
Every ratio is computed from Haemonetics's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.